NewGLAB CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
September 27, 2020
Share
NewGLAB CO.,LTD (KOSDAQ:A214870) announced a private placement of series 6 non-guaranteed private convertible bonds with bearer interest for gross proceeds of KRW 35,000,000,000 on September 28, 2020. The transaction will include participation from returning investor DB Financial Investment Co.,Ltd., Investment Arm. The bonds are zero coupon bonds and bears fixed interest rate to maturity of 2%. The bonds will mature on October 20, 2023. The bonds are 100% convertible into 2,287,432 shares, representing 7.29%, at a fixed conversion price of KRW 15,301 per share. The conversion period starts from October 20, 2021 and ends on September 20, 2023. The subscription date is September 28, 2020 and the transaction is expected to close on October 20, 2020. The transaction has been approved by the company's board of directors.
NewGLab Pharma Co Ltd, formerly NewGLab Co Ltd, is a company mainly engaged in the manufacturing and sale of closed-circuit television (CCTV) cameras. The Company's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The Company distributes its products within domestic market and to overseas markets.